close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PureTech Health plc - American Depositary Shares (NQ:PRTC)

17.46 UNCHANGED
Last Price Updated: 3:55 PM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about PureTech Health plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Results of Annual General Meeting
From PureTech Health plc
Via Business Wire
News headline image
PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300
From PureTech Health plc
Via Business Wire
News headline image
PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute “Long” COVID with Respiratory Complications
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer
From PureTech Health plc
Via Business Wire
News headline image
PureTech to Present at the Jefferies Healthcare Conference
From PureTech Health
Via Business Wire
News headline image
PureTech Founded Entity Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Vedanta Biosciences Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
From PureTech Health plc
Via Business Wire
News headline image
Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
From Vedanta Biosciences
Via Business Wire
News headline image
PureTech to Present at the UBS Global Healthcare Conference
From PureTech Health plc
Via Business Wire
News headline image
PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022
From PureTech Health plc
Via Business Wire
News headline image
PureTech Announces Share Buyback Program Update
From PureTech Health plc
Via Business Wire
News headline image
PureTech Announces Share Buyback Program of up to $50 Million
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study
From PureTech Health plc
Via Business Wire
News headline image
PureTech Announces Annual Results for Year Ended December 31, 2021
From PureTech
Via Business Wire
News headline image
PureTech Founded Entity Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303 in Cell Host & Microbe and Highlights Planned Presentations of Phase 2 VE303 Results
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Akili Announces American Journal of Psychiatry Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults w/ Major Depressive Disorder When Combined w/ Antidepressant Medication
From PureTech Health plc
Via Business Wire
News headline image
PureTech Announces Publication of Research from Collaborators Demonstrating PureTech’s Glyph™ Platform Enhances Oral Absorption of Buprenorphine (a Clinically-Validated Opioid Replacement Therapy)
From PureTech Health plc
Via Business Wire
News headline image
PureTech Health: Notice of Results
From PureTech Health
Via Business Wire
News headline image
PureTech Appoints Sharon Barber-Lui to Board of Directors & Audit Committee
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Akili Appoints Game Industry Veteran Behind Bejeweled, Plants vs. Zombies as Chief Product Officer
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Akili Announces PLOS ONE Publication of Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I
From PureTech Health
Via Business Wire
News headline image
PureTech to Present at the SVB Leerink 11th Annual Global Healthcare Conference
From PureTech Health
Via Business Wire
News headline image
PureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Norms
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar
From PureTech Health plc
Via Business Wire
News headline image
PureTech to Present at 40th Annual J.P. Morgan Healthcare Conference
From PureTech Health plc
Via Business Wire
News headline image
PureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to Pirfenidone
From PureTech Health plc
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today